Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

This research provides updated recommendations for preventing migraine headaches. The authors aimed to identify effective pharmacologic therapies for migraine prevention. They analyzed studies published from June 1999 to May 2009. A structured review process was used to assess medication efficacy. The author panel reviewed 284 abstracts and found 29 relevant articles. Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective. These medications should be provided to patients to reduce attack frequency. Frovatriptan is specifically effective for preventing menstrual migraine. However, lamotrigine was found to be ineffective for migraine prevention. The findings emphasize the importance of using proven therapies to manage migraines effectively. By focusing on these medications, clinicians can help improve patients' quality of life. Ultimately, this research supports evidence-based practices in migraine care and guides treatment decisions for healthcare professionals. Clinical relevance: This research identifies effective medications for migraine prevention, enhancing treatment strategies for patients.